MNPR Operating Cash Flow (Statement)

Monopar Therapeutics Inc · Operating Cash Flow (Statement)

MNPR logo

MNPR Operating Cash Flow (Statement)

Latest reported-$3.25B
MNPR Quarterly Cash from Operations (-$257.44K → -$3.25B)
High-resolution chart · PNG

MNPR operating cash flow (statement) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Monopar Therapeutics Inc Operating Cash Flow (Statement) — Quarterly (USD)
Period endingOperating Cash Flow (Statement) (USD)
-3,247,437,000
-3,473,906
-3,370,072
-2,090,532
-1,077,371
-5,663,316
-1,998,418
-1,073,500
-1,676,798
-1,655,423
-1,545,899
-1,939,813
-2,101,468
-2,271,113
-1,301,806
-2,148,478
-1,267,313
-2,467,500
-2,031,905
-1,941,316
-1,406,120
-1,938,060
-1,240,696
-1,300,534
-995,474
-1,125,570
-668,704
-613,268
-739,735
-995,972
-725,482
-599,563
-752,863
-808,849
-816,021
-1,194,833
-305,128
-311,486
-467,333
-212,428
-257,435
-257,436
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.